Evidence map›Paper›PMID 34695789›Full record

ArticleThe American journal of tropical medicine and hygiene2021

Population-Based Prevalence of Ocular Chlamydia trachomatis Infection among Infants in the Trachoma Endemic Amhara Region, Ethiopia.

Scott D Nash, Ambahun Chernet, Tigist Astale, Eshetu Sata, Mulat Zerihun, Andrew W Nute, Kimberly A Jensen, Demelash Gessese, Zebene Ayele, Berhanu Melak and 4 more

Open access · hybridAbstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Trachoma.Nature reviews. Disease primers · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Scott D NashTrachoma Control Program, The Carter Center, Atlanta, Georgia.
Ambahun ChernetTrachoma Control Program, The Carter Center, Addis Ababa, Ethiopia.
Tigist AstaleTrachoma Control Program, The Carter Center, Addis Ababa, Ethiopia.
Eshetu SataTrachoma Control Program, The Carter Center, Addis Ababa, Ethiopia.
Mulat ZerihunTrachoma Control Program, The Carter Center, Addis Ababa, Ethiopia.
Andrew W NuteTrachoma Control Program, The Carter Center, Atlanta, Georgia.
Kimberly A JensenTrachoma Control Program, The Carter Center, Atlanta, Georgia.
Demelash GesseseTrachoma Control Program, The Carter Center, Addis Ababa, Ethiopia.
Zebene AyeleTrachoma Control Program, The Carter Center, Addis Ababa, Ethiopia.
Berhanu MelakTrachoma Control Program, The Carter Center, Addis Ababa, Ethiopia.
Mahteme HaileResearch and Technology Transfer Directorate, Amhara Public Health Institute, Bahir Dar, Ethiopia.
Taye ZeruResearch and Technology Transfer Directorate, Amhara Public Health Institute, Bahir Dar, Ethiopia.
Zerihun TadesseTrachoma Control Program, The Carter Center, Addis Ababa, Ethiopia.
E Kelly CallahanTrachoma Control Program, The Carter Center, Atlanta, Georgia.
The Carter Center · ETCarter Center · USEthiopian Public Health Institute · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infants ages < 6 months do not receive azithromycin as part of trachoma control and thus may serve as an infection reservoir in persistently endemic districts. The aim of this study was to determine the population-based Chlamydia trachomatis infection prevalence and infectious load among infants ages 1-12 months in persistently trachoma endemic districts in Amhara, Ethiopia. Across six districts, 475 infants were enumerated, and of these 464 (97.7%) were swabbed for infection testing. The C. trachomatis infection prevalence in the study area among infants was 0.2% (95% CI: 0.0-1.5). Among children ages 0-5 years positive for C. trachomatis, the median load was 31 elementary bodies (EB) (Inter quartile range: 7-244 EB), and the infection-positive infant had a load of 7,755 EB. While it is worth reconsidering azithromycin treatment recommendations for the potential mortality benefits, these results do not support lowering the treatment age for trachoma control.

Indexed as

Anti-Bacterial AgentsAzithromycinChild, PreschoolChlamydia trachomatisEthiopiaEyeFemaleHumansInfantInfant, NewbornInfant, Newborn, DiseasesMaleNeglected DiseasesPrevalenceTrachomaAnti-Bacterial AgentsAzithromycin

Identifiers

PMID34695789
PMCPMC8733485
OpenAlexW3209150473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.